X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-14 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $155.46 | -875 | 123,859 | -1% | -$136,027 | ||||||
2025-08-14 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $155.46 | -678 | 152,747 | 0% | -$105,401 | ||||||
2025-08-13 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $19.50 | -43,019 | 331,055 | -12% | -$839,043 | ||||||
| D | 2025-08-13 | LH | Labcorp Holdings Inc. | Van Der Vaart Sandra D | EVP, GC | S - Sale+OE | $271.43 | -3,903 | 2,274 | -63% | -$1,059,371 | |||||
2025-08-13 | RDNT | Radnet, Inc. | Katz David Jeffrey | EVP, GC | S - Sale | $68.31 | -17,000 | 86,774 | -16% | -$1,161,270 | ||||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $0.42 | -988 | 250,794 | 0% | -$411 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $0.42 | -3,772 | 728,824 | -1% | -$1,570 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $0.42 | -476 | 140,065 | 0% | -$198 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $0.42 | -442 | 157,878 | 0% | -$184 | |||||
| D | 2025-08-13 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $0.42 | -228 | 18,375 | -1% | -$95 | |||||
2025-08-13 | EXAS | Exact Sciences Corp | Doyle James Edward | Dir | S - Sale | $42.02 | -1,485 | 59,962 | -2% | -$62,400 | ||||||
2025-08-11 | LH | Labcorp Holdings Inc. | Schechter Adam H | Pres, CEO | S - Sale | $266.78 | -5,643 | 93,319 | -6% | -$1,505,440 | ||||||
| M | 2025-08-08 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $157.84 | -6,070 | 310,816 | -2% | -$958,059 | |||||
| M | 2025-08-08 | FTRE | Fortrea Holdings Inc. | Neupert Peter M | Dir | P - Purchase | $6.51 | +62,500 | 98,132 | +175% | +$407,150 | |||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $2.54 | -8,571 | 832,294 | -1% | -$21,770 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $2.54 | -6,460 | 188,940 | -3% | -$16,408 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $2.54 | -6,447 | 127,751 | -5% | -$16,375 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $2.54 | -5,962 | 108,577 | -5% | -$15,143 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $2.54 | -7,094 | 160,888 | -4% | -$18,019 | ||||||
2025-08-08 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $2.54 | -5,800 | 290,848 | -2% | -$14,732 | ||||||
| D | 2025-08-06 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | S - Sale+OE | $175.00 | -5,535 | 19,219 | -22% | -$968,625 | |||||
2025-08-05 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $12.79 | -2,688 | 112,930 | -2% | -$34,381 | ||||||
2025-08-01 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $132.88 | -5,807 | 163,593 | -3% | -$771,656 | ||||||
2025-08-01 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale | $133.17 | -2,496 | 5,763 | -30% | -$332,395 | ||||||
2025-08-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $132.89 | -3,000 | 123,059 | -2% | -$398,657 | ||||||
2025-08-05 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $2.50 | -225 | 58,702 | 0% | -$563 | ||||||
| DM | 2025-07-30 | DGX | Quest Diagnostics Inc | Kuppusamy Karthik | SVP, Clinical Solutions | S - Sale+OE | $167.95 | -10,479 | 10,437 | -50% | -$1,759,931 | |||||
2025-07-30 | LH | Labcorp Holdings Inc. | Gilliland Dwight Gary | Dir | S - Sale | $264.95 | -2,000 | 6,656 | -23% | -$529,900 | ||||||
2025-07-29 | LH | Labcorp Holdings Inc. | Wilkinson Peter J | SVP, Chief Accounting Officer | S - Sale | $261.02 | -202 | 1,852 | -10% | -$52,727 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $139.81 | -6,092 | 169,400 | -3% | -$851,712 | ||||||
| M | 2025-07-28 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $138.36 | -5,064 | 65,430 | -7% | -$700,670 | |||||
2025-07-28 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $139.81 | -479 | 316,886 | 0% | -$66,968 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $139.81 | -1,718 | 2,390,852 | 0% | -$240,191 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $139.81 | -2,206 | 126,059 | -2% | -$308,417 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $139.81 | -1,710 | 151,750 | -1% | -$239,072 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $139.81 | -1,994 | 202,164 | -1% | -$278,778 | ||||||
2025-07-28 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $6.57 | -452 | 124,505 | 0% | -$2,970 | ||||||
2025-07-28 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $6.57 | -641 | 164,458 | 0% | -$4,211 | ||||||
2025-07-28 | CELC | Celcuity Inc. | Dalvey David | Dir | S - Sale | $44.07 | -109,325 | 125,000 | -47% | -$4,818,370 | ||||||
2025-07-30 | OPGN | Opgen Inc | Aei Capital Ltd | 10% | P - Purchase | $4.79 | +1,000 | 7,646,603 | 0% | +$4,790 | ||||||
2025-07-24 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $280.00 | -3,500 | 8,666 | -29% | -$980,000 | ||||||
2025-07-24 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $280.00 | -3,500 | 8,666 | -29% | -$980,000 | ||||||
| DM | 2025-07-22 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $139.94 | -2,170 | 70,494 | -3% | -$303,669 | |||||
| D | 2025-07-21 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $139.29 | -602 | 71,414 | -1% | -$83,853 | |||||
| D | 2025-07-21 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $139.29 | -1,622 | 175,492 | -1% | -$225,928 | |||||
| DM | 2025-06-18 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $169.79 | -20,372 | 204,158 | -9% | -$3,459,007 | |||||
| D | 2025-07-21 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $139.29 | -93 | 317,365 | 0% | -$12,954 | |||||
| M | 2025-05-27 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $154.22 | -1,940 | 128,265 | -1% | -$299,180 | |||||
| M | 2025-05-27 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $153.50 | -1,777 | 153,460 | -1% | -$272,770 | |||||
2025-07-16 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $149.96 | -3,070 | 317,268 | -1% | -$460,388 | ||||||
2025-07-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $48.20 | -116 | 7,324 | -2% | -$5,591 | ||||||
2025-07-17 | GH | Guardant Health, Inc. | Potter Myrtle S | Dir | S - Sale | $48.20 | -26 | 18,196 | 0% | -$1,253 | ||||||
2025-07-15 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $38.93 | -8,000 | 286,020 | -3% | -$311,440 | ||||||
2025-07-07 | CDNA | Caredx, Inc. | Maag Peter | Dir | S - Sale | $18.58 | -10,000 | 308,846 | -3% | -$185,831 | ||||||
2025-07-07 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $2.36 | -234 | 58,927 | 0% | -$552 | ||||||
2025-07-02 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $160.10 | -3,000 | 320,338 | -1% | -$480,309 | ||||||
2025-07-01 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $166.53 | -5,343 | 348,104 | -2% | -$889,778 | ||||||
2025-07-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $166.77 | -3,000 | 130,205 | -2% | -$500,305 | ||||||
| D | 2025-07-01 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale+OE | $167.36 | -4,299 | 8,118 | -35% | -$719,491 | |||||
2025-07-01 | GRAL | Grail, Inc. | Ding Chun R | 10% | S - Sale | $49.53 | -339,800 | 3,305,055 | -9% | -$16,830,151 | ||||||
| D | 2025-07-01 | GH | Guardant Health, Inc. | Talasaz Amirali | Co-CEO | S - Sale+OE | $50.88 | -100,000 | 1,983,665 | -5% | -$5,087,630 | |||||
2025-07-01 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $265.00 | -500 | 12,454 | -4% | -$132,500 | ||||||
2025-06-30 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $52.00 | -9,692 | 492,076 | -2% | -$503,984 | ||||||
2025-06-27 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.30 | -22,576 | 331,055 | -6% | -$458,293 | ||||||
| D | 2025-06-20 | CAI | Caris Life Sciences, Inc. | Denton John Russel | See Remarks | P - Purchase | $21.00 | +7,500 | 128,591 | +6% | +$157,500 | |||||
2025-06-20 | CAI | Caris Life Sciences, Inc. | Brille Brian J | See Remarks | P - Purchase | $21.00 | +30,000 | 662,428 | +5% | +$630,000 | ||||||
2025-06-18 | CDNA | Caredx, Inc. | Valantine Hannah | Dir | S - Sale | $19.16 | -10,570 | 38,994 | -21% | -$202,566 | ||||||
| M | 2025-05-15 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $155.26 | -54,000 | 2,392,570 | -2% | -$8,384,150 | |||||
| M | 2025-06-18 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $165.93 | -6,070 | 323,338 | -2% | -$1,007,220 | |||||
| D | 2025-06-18 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale+OE | $49.47 | -3,213 | 7,190 | -31% | -$158,947 | |||||
| D | 2025-06-18 | GH | Guardant Health, Inc. | Potter Myrtle S | Dir | S - Sale+OE | $49.47 | -26 | 18,154 | 0% | -$1,286 | |||||
| D | 2025-06-17 | GH | Guardant Health, Inc. | Clark Ian T | Dir | S - Sale+OE | $48.38 | -6,672 | 9,851 | -40% | -$322,819 | |||||
2025-06-17 | CDNA | Caredx, Inc. | Maag Peter | Dir | S - Sale | $19.24 | -10,000 | 318,846 | -3% | -$192,420 | ||||||
2025-06-13 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale | $26.66 | -4,590 | 13,907 | -25% | -$122,388 | ||||||
2025-06-13 | VCYT | Veracyte, Inc. | Bhanji Muna | Dir | S - Sale | $26.67 | -4,589 | 29,989 | -13% | -$122,367 | ||||||
| D | 2025-06-16 | GH | Guardant Health, Inc. | Potter Myrtle S | Dir | S - Sale+OE | $49.70 | -2,626 | 18,180 | -13% | -$130,512 | |||||
| D | 2025-06-13 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale+OE | $47.22 | -3,337 | 11,150 | -23% | -$157,573 | |||||
2025-06-13 | EXAS | Exact Sciences Corp | Zanotti Katherine S | Dir | S - Sale | $53.20 | -3,207 | 72,759 | -4% | -$170,612 | ||||||
2025-06-12 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $42.30 | -9,692 | 501,768 | -2% | -$410,019 | ||||||
| D | 2025-06-11 | CDNA | Caredx, Inc. | Hagstrom William A | Dir | S - Sale+OE | $19.90 | -19,391 | 53,979 | -26% | -$385,918 | |||||
2025-06-10 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $1.48 | -965 | 134,198 | -1% | -$1,428 | ||||||
2025-06-10 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $1.48 | -1,439 | 167,982 | -1% | -$2,130 | ||||||
2025-06-11 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $260.00 | -500 | 12,954 | -4% | -$130,000 | ||||||
2025-06-10 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale | $164.44 | -4,000 | 5,704 | -41% | -$657,761 | ||||||
| M | 2025-06-09 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $1.44 | -6,680 | 296,648 | -2% | -$9,600 | |||||
2025-06-10 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $1.48 | -1,311 | 195,400 | -1% | -$1,940 | ||||||
2025-06-10 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $1.48 | -667 | 114,539 | -1% | -$987 | ||||||
| M | 2025-06-09 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $1.44 | -26,386 | 840,865 | -3% | -$37,899 | |||||
| M | 2025-06-05 | GH | Guardant Health, Inc. | Talasaz Amirali | Co-CEO | S - Sale | $50.09 | -119,284 | 2,069,456 | -5% | -$5,974,364 | |||||
| D | 2025-06-06 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale+OE | $1.58 | -107 | 59,161 | 0% | -$169 | |||||
2025-06-04 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $27.20 | -2,809 | 94,540 | -3% | -$76,410 | ||||||
2025-06-05 | RDNT | Radnet, Inc. | Murdock Michael N | EVP, Mergers, Acquisitions | S - Sale | $58.05 | -11,132 | 43,084 | -21% | -$646,213 | ||||||
2025-06-03 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale | $46.39 | -4,000 | 18,765 | -18% | -$185,562 | ||||||
2025-06-03 | LH | Labcorp Holdings Inc. | Caveney Brian J | EVP, Pres of ED, CMO, CSO | S - Sale | $247.00 | -2,000 | 30,067 | -6% | -$494,000 | ||||||
2025-06-02 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $157.07 | -3,000 | 133,205 | -2% | -$471,212 | ||||||
2025-06-02 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $157.10 | -6,111 | 179,071 | -3% | -$960,062 | ||||||
| D | 2025-06-03 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $4.17 | -3,130 | 46,549 | -6% | -$13,052 | |||||
| D | 2025-06-03 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $4.17 | -3,130 | 48,344 | -6% | -$13,052 | |||||
| D | 2025-06-03 | FTRE | Fortrea Holdings Inc. | Hanson James S. | GC | S - Sale+OE | $4.17 | -2,191 | 14,981 | -13% | -$9,136 | |||||
2025-06-02 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale | $41.66 | -100 | 7,746 | -1% | -$4,166 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |